Stemcell Technologies UK Ltd
Registered name: STEMCELL TECHNOLOGIES UK LTD
Stemcell Technologies UK Ltd made £1.3m profit in the year to 30 Jun 2024 (revenue not disclosed).
Stemcell Technologies UK Ltd reported £1.3m profit in the year to 30 Jun 2024; its revenue was not disclosed. It had 232 employees. The company is classified under “research and experimental development on biotechnology” and is based in Cambridge; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Cambridge, East of England
- Age
- 12 yrs · since 2014
- Type
- Private Limited Company
Key figures
This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Jun 2022 | 30 Jun 2023 | 30 Jun 2024 |
|---|---|---|---|
| Disclosure | No P&L | Profit only | Profit only |
| Profit & loss | |||
| Revenue (turnover) | — | — | — |
| Profit after tax | — | −£160k | £1.3m |
| Profit (best available) | — | −£160k | £1.3m |
| Employees (average) | 172 | 201 | 232 |
| Ratios | |||
| Profit margin | — | — | — |
| Profit per employee | — | −£796 | £5.5k |
| Growth (year on year) | |||
| Headcount growth | — | ▲16.9% | ▲15.4% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £350k | £621k | £260k |
| Net assets | £1.1m | £973k | £2.3m |
| Current assets | £4.2m | £4.8m | £4.7m |
| Debtors | £2.2m | £2.4m | £2.5m |
| Deferred income | £1.2m | £1.2m | £1.1m |
| Cash from operations | −£317k | −£374k | −£1.1m |
| Source | Accounts · bulk data Mar 2024 | Accounts · bulk data Mar 2024 | FullAccounts · bulk data Feb 2025 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- £5.5k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲132%
- Now £2.3m
- Cash at bank
- ▼58%
- Now £260k
- Headcount
- ▲15%
- Now 232
- Deferred income
- ▼9%
- Now £1.1m
- Fixed assets
- —
- Now —
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Subsidiaries (1)
- Cellular Highways LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Astex Therapeutics LimitedCambridge · Research and experimental development on biotechnology
- Revenue
- £404m
- Profit
- £283m
- Staff
- 183
- Amphista Therapeutics LimitedCambridge · Research and experimental development on biotechnology
- Revenue
- £33.9m
- Profit
- £19.8m
- Staff
- 56
- Charles River U.K. LimitedKent · Research and experimental development on biotechnology
- Revenue
- £22.2m
- Profit
- £18.8m
- Staff
- 129
- Qiagen Manchester LimitedManchester · Research and experimental development on biotechnology
- Revenue
- £53.7m
- Profit
- £11.8m
- Staff
- 239
- Alchemab Therapeutics LtdLondon · Research and experimental development on biotechnology
- Revenue
- £30m
- Profit
- £8.3m
- Staff
- 55
- Ligand UK Development LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £8.7m
- Profit
- £6m
- Staff
- —
Sources
Latest figures from FullAccounts for the year to 30 Jun 2024 (profit £1.3m), from the Companies House accounts bulk data published Feb 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.